To the top

Page Manager: Webmaster
Last update: 9/11/2012 3:13 PM

Tell a friend about this page
Print version

BMP4 gene therapy enhance… - University of Gothenburg, Sweden Till startsida
Sitemap
To content Read more about how we use cookies on gu.se

BMP4 gene therapy enhances insulin sensitivity but not adipose tissue browning in obese mice

Journal article
Authors Jenny M Hoffmann
John Grünberg
Ann Hammarstedt
T. Kroon
Thomas U. Greiner
S. Maurer
I. Elias
Vilborg Palsdottir
F. Bosch
Jeremie Boucher
Shahram Hedjazifar
Ulf Smith
Published in Molecular Metabolism
Volume 32
Pages 15-26
ISSN 2212-8778
Publication year 2020
Published at Wallenberg Laboratory
Institute of Neuroscience and Physiology, Department of Physiology
Institute of Medicine, Department of Molecular and Clinical Medicine
Pages 15-26
Language en
Links dx.doi.org/10.1016/j.molmet.2019.11...
Keywords Obesity, Gene therapy, Insulin sensitivity, Adipose tissue, Skeletal, muscle, Liver, white, adipogenesis, metabolism, activation, Endocrinology & Metabolism
Subject categories Endocrinology and Diabetes

Abstract

Objective: Bone morphogenetic protein 4 (BMP4) adeno-associated viral vectors of serotype 8 (AAV8) gene therapy targeting the liver prevents the development of obesity in initially lean mice by browning the large subcutaneous white adipose tissue (WAT) and enhancing energy expenditure. Here, we examine whether this approach could also reduce established obesity. Methods: Dietary-induced obese C57BL6/N mice received AAV8 BMP4 gene therapy at 17-18 weeks of age. They were kept on a high-fat diet and phenotypically characterized for an additional 10-12 weeks. Following termination, the mice underwent additional characterization in vitro. Results: Surprisingly, we observed no effect on body weight, browning of WAT, or energy expenditure in these obese mice, but whole-body insulin sensitivity and glucose tolerance were robustly improved. Insulin signaling and insulin-stimulated glucose uptake were increased in both adipose cells and skeletal muscle. BMP4 also decreased hepatic glucose production and reduced gluconeogenic enzymes in the liver, but not in the kidney, in addition to enhancing insulin action in the liver. Conclusions: Our findings show that BMP4 prevents, but does not reverse, established obesity in adult mice, while it improves insulin sensitivity independent of weight reduction. The BMP antagonist Noggin was increased in WAT in obesity, which may account for the lack of browning. (C) 2019 The Author(s). Published by Elsevier GmbH.

Page Manager: Webmaster|Last update: 9/11/2012
Share:

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?

Denna text är utskriven från följande webbsida:
http://www.gu.se/english/research/publication/?publicationId=290702
Utskriftsdatum: 2020-07-08